New assessment of therapeutic response to sorafenib for advanced hepatocellular carcinoma

New assessment of therapeutic response to sorafenib for advanced hepatocellular carcinoma - New assessment of therapeutic response to sorafenib for advanced hepatocellular carcinoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017953

Enrollment

Registered

2015-06-19

Start date

2015-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Child-Pugh class A 2) Barcelona Clinic Liver Cancer stage C 3) ECOG performance status 0 or 1

Exclusion criteria

Exclusion criteria: No follow-up CT images are available

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactYasunori Kawaguchi

Saga-Ken Medical Centre Koseikan Department of Hepatobiliary and Pancreatology

kawaguy222@gmail.com0952-24-2171

Outcome results